Promising results for new quality of vision metric

Article

It is mandatory to develop precise , reproducible and accurate methodologies to obtain objective measurements of quality of vision, namely night vision, in order to create surgical techniques that will eliminate post-refractive vision disturbances, Joachim Murta said.

It is mandatory to develop precise , reproducible and accurate methodologies to obtain objective measurements of quality of vision, namely night vision, in order to create surgical techniques that will eliminate post-refractive vision disturbances, Joachim Murta said.

He added that a study conducted with a new quality of vision metric showed promising results.

Dr Murta of the University Hospital Coimbra, Portugal, performed a prospective study to evaluate the quality of vision in patients undergoing LASIK with either Planoscan or Zyoptix, using a new methodology called Mesopic High Resolution Perimetry. "It uses a frequency doubling technique which is relatively independent of optical factors," said Dr Murta.

The study evaluated contrast sensitivity in patients submitted to LASIK. Mesopic High Resolution Perimetry analysed central vision, while a Optical Quality Analysis System (OQAS) tested peripheral vision.

40 eyes with less than 6 D of myopia and 1.5 D of astigmatism were included. Group I were treated with Planoscan while Group II were treated with Zyoptix. Pre- and postoperative spherical equivalent, mean keratometry, age, OZ, RST, pupil size, aberrometry and subjective rating of night vision complaints were evaluated.

A decreased contrast sensitivity was noted in myopes compared with normal population (p

Dr Murta concluded that the preliminary results obtained are promising for the evaluation of the quality of vision under mesopic conditions.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.